Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1970 May;1(5):431–439. doi: 10.1128/iai.1.5.431-439.1970

Characteristics of Endotoxin-Altering Fractions Derived from Normal Serum III. Isolation and Properties of Horse Serum α2-Macroglobulin

Morimasa Yoshioka 1, Seishi Konno 2
PMCID: PMC415920  PMID: 16557754

Abstract

The endotoxin-altering activity of fractions isolated from normal horse serum was examined by incubation of Salmonella typhosa strain 0-901 endotoxin (Boivin) in a solution of the fraction, and subsequent quantitation of any diminution in the capacity of endotoxin to be precipitated by specific anti-endotoxin antiserum. The horse serum fraction isolated by precipitation with ammonium sulfate at a concentration between 1.6 and 2.7 m was incubated with Pronase PA and then with trypsin. When this partly digested fraction was passed twice through a Sephadex G-200 column and eluted with 0.2 m tris(hydroxymethyl)aminomethane buffer, most of the endotoxinaltering activity was found in the first protein peak designated F-1a. F-1a was found to be homogeneous and corresponded to an α2-macroglobulin by the techniques of electrophoresis, immunodiffusion, and ultracentrifugation. Approximately 100-fold more F-1a than endotoxin was needed to reduce the antigenicity of the endotoxin by one-half. Alteration was increased when F-1a was incubated with the endotoxin at acid pH or at 45 C rather than at 37 C and was lost after heating F-1a at 56 C for 30 min. N-ethylmaleimide increased the endotoxin-altering activity of horse serum, F-1a, and human plasma fraction III0, whereas p-chloromercuribenzoate did not. On the other hand, diazonium-1-H-tetrazole, iodoacetic acid, and benzylchloride suppressed the activity of F-1a. When the interaction of endotoxin and F-1a was examined by immunodiffusion techniques, depolymerization of the endotoxin molecule was indicated. The endotoxin-altering factor of horse serum is discussed in relation to the mechanisms of other known reagents, such as deoxycholate and sodium lauryl sulfate.

Full text

PDF
431

Images in this article

434Image
on p.434
434Image
on p.434
435Image
on p.435
436Image
on p.436

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEER H., STAEHELIN T., DOUGLAS H., BRAUDE A. I. RELATIONSHIP BETWEEN PARTICLE SIZE AND BIOLOGICAL ACTIVITY OF E. COLI BOIVIN ENDOTOXIN. J Clin Invest. 1965 Apr;44:592–602. doi: 10.1172/JCI105172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CLUFF L. E., BENNETT I. L., Jr Factors influencing the alteration of the pyrogenic action of endotoxin by serum. Bull Johns Hopkins Hosp. 1957 Nov;101(5):281–291. [PubMed] [Google Scholar]
  3. FREEDMAN H. H., SULTZER B. M. Dissociation of the biological properties of bacterial endotoxin by chemical modification of the molecule. J Exp Med. 1962 Dec 1;116:929–942. doi: 10.1084/jem.116.6.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Frosch B., Wagener H. Quantitative determination of conjugated bile acids in serum in acute hepatitis. Nature. 1967 Jan 28;213(5074):404–405. doi: 10.1038/213404a0. [DOI] [PubMed] [Google Scholar]
  5. Horinishi H., Kurihara K., Shibata K. States of amino acid residues in proteins. VI. Heme-linked histidine residues in cytochrome c as determined with diazonium-1-H-tetrazole. Arch Biochem Biophys. 1965 Sep;111(3):520–528. doi: 10.1016/0003-9861(65)90230-4. [DOI] [PubMed] [Google Scholar]
  6. KIM Y. B., WATSON D. W. INACTIVATION OF GRAM-NEGATIVE BACTERIAL ENDOTOXINS BY PAPAIN. Proc Soc Exp Biol Med. 1964 Jan;115:140–142. doi: 10.3181/00379727-115-28852. [DOI] [PubMed] [Google Scholar]
  7. Martin W. J., Marcu S. Detoxified bacterial endotoxins. I. Preparation and biological properties of an acetylated crude endotoxin from Salmonella typhimurium. J Bacteriol. 1966 Apr;91(4):1453–1459. doi: 10.1128/jb.91.4.1453-1459.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. OROSZLAN S. I., MORA P. T., SHEAR M. J. REVERSIBLE INACTIVATION OF AN ENDOTOXIN BY INTRACELLULAR PROTEIN. Biochem Pharmacol. 1963 Oct;12:1131–1146. doi: 10.1016/0006-2952(63)90087-x. [DOI] [PubMed] [Google Scholar]
  9. Previte J. J., Chang Y., el-Bisi H. M. Detoxification of Salmonella typhimurium lipopolysaccharide by ionizing radiation. J Bacteriol. 1967 May;93(5):1607–1614. doi: 10.1128/jb.93.5.1607-1614.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. ROSEN F. S., SKARNES R. C., LANDY M., SHEAR M. J. Inactivation of endotoxin by a humoral component. III. Role of divalent cation and a dialyzable component. J Exp Med. 1958 Nov 1;108(5):701–711. doi: 10.1084/jem.108.5.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. RUDBACH J. A., RIBI E., MILNER K. C. REACTIVATION OF PAPAIN-TREATED ENDOTOXIN. Proc Soc Exp Biol Med. 1965 May;119:115–118. doi: 10.3181/00379727-119-30112. [DOI] [PubMed] [Google Scholar]
  12. Ribi E., Anacker R. L., Brown R., Haskins W. T., Malmgren B., Milner K. C., Rudbach J. A. Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate. J Bacteriol. 1966 Nov;92(5):1493–1509. doi: 10.1128/jb.92.5.1493-1509.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rudbach J. A., Johnson A. G. Alteration and restoration of endotoxin activity after complexing with plasma proteins. J Bacteriol. 1966 Oct;92(4):892–898. doi: 10.1128/jb.92.4.892-898.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. SKARNES R. C., ROSEN F. S., SHEAR M. J., LANDY M. Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma. J Exp Med. 1958 Nov 1;108(5):685–699. doi: 10.1084/jem.108.5.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. STAUCH J. E., JOHNSON A. G. The alteration of bacterial endotoxins by human and rabbit serum. J Immunol. 1959 Mar;82(3):252–263. [PubMed] [Google Scholar]
  16. Skarnes R. C. The inactivation of endotoxin after interaction with certain proteins of normal serum. Ann N Y Acad Sci. 1966 Jun 30;133(2):644–662. doi: 10.1111/j.1749-6632.1966.tb52395.x. [DOI] [PubMed] [Google Scholar]
  17. YOSHIOKA M., HAMASAKA M., SAITO Y., KONNO S. CHARACTERISTICS OF ENDOTOXIN ALTERING FRACTIONS DERIVED FROM NORMAL SERUM. I. SEPARATION OF BETA LIPOPROTEINS AND LIPID FROM HUMAN SERUM FRACTIONS. Kitasato Arch Exp Med. 1963 Dec;36:27–36. [PubMed] [Google Scholar]
  18. YOSHIOKA M., JOHNSON A. G. Characteristics of endotoxin altering fractions derived from normal human serum. J Immunol. 1962 Sep;89:326–335. [PubMed] [Google Scholar]
  19. Yoshioka M., Konno S., Saito Y. Characteristics of endotoxin altering fractions derived from normal serum. II. Preliminary examination of horse serum fractions. Kitasato Arch Exp Med. 1965 Dec;38(1):1–15. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES